Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis

Clinica Chimica Acta

Volumn 376, Issue 1-2, 2007, Pages 101-107

  Lo, Wan Yu ^a   Tsai, Ming Hsui ^a   Tsai, Yuhsin ^b   Hua, Chun Hung ^a   Tsai, Fuu Jen ^a   Huang, Shiuan Yi ^a   Tsai, Chang Hai ^c   Lai, Chien Chen ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

LC MS MS; Oral cancer; Oral squamous cell carcinoma (OSCC); Proteomics; Real time quantitative RT PCR

Indexed keywords

ALPHA CRYSTALLIN; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN 27; MYOSIN LIGHT CHAIN; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; TROPOMYOSIN; VIMENTIN;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33845284524     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.06.030     Document Type: Article

References (54)

1. Petersen P.E. Continuous improvement of oral health in the 21st century-the approach of the WHO global oral health programme (2003), World Health Organization, Geneva
2. Fearlay J., Bray F., Pisani P., and Parkin D.M. Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC cancer base vol. 5 (2001), IARC Press, Lyon
3. Chen C.H. An epidemiological study of oral squamous cell carcinoma in southern Taiwan. J Formosan Dent Assoc 10 (1987) 268-274
4. Department of Health. Cancer registry annual report in Taiwan area, 2003. Taipei: Department of Health. The Executive Yuan, ROC; 2005.
5. Yang Y.-Y., Koh L.-W., and Yang C.-C. Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn J Clin Oncol 34 (2004) 176-183
6. Chen P.C., Pan C.C., Kuo C., and Lin C.P. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study. Arch Pathol Lab Med 130 (2006) 57-61
7. Chen I.H., Chang J.T., Liao C.T., Wang H.M., Hsieh L.L., and Cheng A.J. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89 (2003) 681-686
8. Turhani D., Krapfenbauer K., Thurnher D., Langen H., and Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27 7 (2006) 1417-1423
9. Gstaiger M., Jordan R., Lim M., et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 98 (2001) 5043-5048
10. Huang X., Gollin S.M., Raja S., and Godfrey T.E. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A 99 (2002) 11369-11374
11. Sugimura T., Kumimoto H., Tohnai I., et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J. Oral Pathol. & Med. 35 (2006) 11-18
12. Kallioniemi O. Medicine: profile of a tumour. Nature 428 (2004) 379-382
13. Geho D.H., Petricoin E.F., and Loitta L.A. Blasting into the microworld of tissue proteomics: a new window on cancer: commentary re S. A. Schwartz et al., protein profiling in brain tumors using mass spectrometry feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10 (2004) 825-827
14. Herrmann P.C., Liotta L.A., and Petricoin III E.F. Cancer proteomics: the state of the art. Dis Markers 17 (2001) 49-57
15. Xiao X., Liu D., Tang Y., et al. Development of proteomic patterns for detecting lung cancer. Dis Markers 19 (2003-2004) 33-39
16. Wulfkuhle J.F., McLean K.C., Paweletz C.P., et al. New approaches to proteomic analysis of breast cancer. Proteomics 1 (2001) 1205-1215
17. Paweletz C.P., Trock B., Pennanen M., et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 17 (2001) 301-307
18. Feldman A.L., Espina V., Petricoin E.F., Liotta L.A., and Rosenblatt K.P. Use of proteomic patterns to screen for gastrointestinal malignancies. Surgery 135 (2004) 243-247
19. He Q., Chen J., Kung H., Yuen A., and Chiu J. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4 (2004) 271-278
20. Wu W., Tang X., Hu W., Lotan R., Hong W.K., and Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19 4 (2002) 319-326
21. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., and Missche S.M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Lectrophoresis 20 (1999) 601-605
22. Terry D.E., Umstot E., and Desiderio D.M. Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests. J. Am. Soc. Mass Spectrom 15 (2004) 784-794
23. Hirosawa M., Hoshida M., Ishikawa M., and Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 9 (1993) 161-167
24. Chang J.T., Chen I.H., Liao C.T., et al. A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients. Clin Biochem 35 (2002) 591-596
25. -ΔΔCT method. Method 25 (2001) 402-408
26. Ashburner M., Ball C.A., Blake J.A., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25 (2000) 25-29
27. Kamata H., and Hirata H. Redox regulation of cellular signalling. Cell Signal 11 (1999) 1-14
28. Klaunig J.E., Xu Y., Isenberg J.S., et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 (1998) 289-295
29. Wispe J.R., Clark J.C., Burhans M.S., Kropp K.E., Korfhagen T.R., and Whitsett J.A. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta 994 (1989) 30-36
30. Scott M.D., Meshnick S.R., and Eaton J.W. Superoxide dismutase amplifies organismal sensitivity to ionizing radiation. J Biol Chem 264 (1989) 2498-2501
31. Wheeler M.D., Smutney O.M., and Samulski R.J. Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice. Mol Cancer Res 1 (2003) 871-881
32. Mashiba H., and Matsunaga K. Device for intracellular increase of oxygen free radicals and inhibition of MethA tumour cell proliferation: in vitro and in vivo studies. Int J Tissue React 10 (1988) 273-280
33. Guyton K.Z., and Kensler T.W. Oxidative mechanisms in carcinogenesis. Br Med Bull 49 (1993) 523-544
34. Qi Y., Chiu J.F., Wang L., Kwong D.L., and He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5 11 (2005) 2960-2971
35. Zhong W., Yan T., Webber M.M., and Oberley T.D. Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal 6 (2004) 513-522
36. Chen J., He Q.Y., Yuen A.P., and Chiu J.F. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4 (2004) 2465-2475
37. Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res 248 (1999) 30-43
38. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., and Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158 9 (1997) 4341-4350
39. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., and Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158 (1997) 4341-4350
40. Landry J., Chre'tien P., Lambert H., et al. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109 (1989) 7-15
41. Charette S.J., Lavoie J.N., Lambert H., and Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20 (2000) 7602-7612
42. Mehlen P., Schultze-Osthoff K., and Arrigo A.P. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. J Biol Chem 271 (1996) 16510-16514
43. Jakob U., Gaestel M., Engel K., and Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem 268 (1993) 1517-1520
44. Porter W., Wang F., Wang W., et al. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10 (1996) 1371-1378
45. Assimakopoulou M., Sotiropoulou-Bonikou G., Maraziotis T., and Varakis I. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study. Anticancer Res 17 (1997) 2677-2682
46. Storm F.K., Gilchrist K.W., Warner T.F., and Mahvi D.M. Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas. Ann Surg Oncol 2 (1995) 43-48
47. Tetu B., Lacasse B., Bouchard H.L., et al. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Cancer Res 52 (1992) 2325-2328
48. Geisler J.P., Geisler H.E., Tammela J., et al. Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma. Gynecol Oncol 69 (1998) 14-16
49. Uozaki H., Ishida T., Kakiuchi C., et al. Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol Res Pract 196 (2000) 665-673
50. King K.L., Li A.F., Chau G.Y., et al. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 88 (2000) 2464-2470
51. Chen J., Kahne T., Rocken C., et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 3 (2004) 1009-1016
52. Sarto C., Valsecchi C., Magni F., et al. Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 4 (2004) 2252-2260
53. Rocchi P., So A., Kojima S., et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res 64 (2004) 6595-6602
54. Ferrarini M., Heltai S., Zocchi M.R., and Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 51 4 (1992) 613-619